Valeant Pharmaceuticals International Posts Loss, Cuts 2013 Sales Forecast

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valeant Pharmaceuticals International Inc posted a quarterly net loss that it attributed in part to restructuring and impairment charges, and Canada’s biggest publicly traded drugmaker cut its full-year revenue outlook. Valeant’s U.S.-listed shares fell nearly 4 per cent in trading before the bell on Thursday.

Help employers find you! Check out all the jobs and post your resume.

Back to news